Published in Pharma Investments, Ventures and Law Weekly, September 19th, 2004
Predictive medicine revenues for the year ended June 30, 2004, increased to a record $43.3 million from $34.7 million for fiscal 2003, an increase of 25%. Fourth quarter predictive medicine revenues were up 40% over the fourth quarter of fiscal 2003 to $13.1 million, from $9.4 million.
The gross profit margin on predictive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.